Bloomage Biotech (688363.SH) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct28

Bloomage Biotech released FY2025 Q3 earnings on October 28 After-Market (BJT), actual revenue CNY 902.71 M (forecast CNY 1.037 B), actual EPS CNY 0.0635 (forecast CNY 0.2587)

01:00

Bloomage Biotech released FY2025 9 Months Earnings on October 28 After-Market (BJT), actual revenue CNY 3.163 B, actual EPS CNY 0.524

01:00

Oct21

Bloomage Biotech to Release FY2025 Q3 Earnings on October 29 After-Market (BJT), Forecast Revenue CNY 1.037 B, EPS CNY 0.2587

01:45

Sep8

Huaxi Biotech Subscribes to Sino Needle's Strategic Placement Shares

05:56

Aug26

Bloomage Biotech released FY2025 Q2 earnings on August 26 During-Market (BJT), actual revenue CNY 1.183 B (forecast CNY 1.668 B), actual EPS CNY 0.2504 (forecast CNY 0.52)

01:00

Bloomage Biotech released FY2025 Semi-Annual Earnings on August 26 During-Market (BJT), Actual Revenue: CNY 2.261 B, Actual EPS: CNY 0.46

01:00

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 902.71 M, Net Income 31.53 M, EPS 0.0635

Aug27

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug26

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 1.183 B, Net Income 118.96 M, EPS 0.2504

View More

Hesai (3Q25 Minutes): Lidar shipments are expected to reach at least 2 million to 3 million units by 2026

11-12 08:58

Hesai: Tesla 'Disdain'? Still Growing Wildly Towards the Sun

11-11 22:16

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More